Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study
- Resource Type
- Article
- Source
- The Lancet; February 2024, Vol. 403 Issue: 10427 p645-656, 12p
- Subject
- Language
- ISSN
- 01406736; 1474547X